SINOVAC has been continuously supporting Bangladesh in defending against various infectious diseases. Our vaccines, including the hepatitis A vaccine Healive®, the COVID-19 vaccine CoronaVac®, as well as quadrivalent and trivalent influenza vaccines, have been approved in Bangladesh. Since 2014, we have supplied nearly 62 million vaccine doses to the country and conducted joint clinical trials for its enterovirus 71 vaccine and poliomyelitis vaccine. Furthermore, we have recently obtained the license to establish private blood banks in local communities.